Marketed Products

Featured Marketed Products

Promacta

Promacta (eltrombopag) is an oral medicine that increases the number of platelets in the blood. Individuals with a low platelet count can be at significant risk of bleeding or death. Low platelet count is also associated with a large number of diseases, allowing Promacta the opportunity to address a wide range of indications.

At a Glance

Partner Indications Royalty
Novartis ITP, HepC, Severe Aplastic Anemia, Oncology 4.7-9.4%

Kyprolis

Kyprolis® (carfilzomib) for Injection is a Proteosome inhibitor indicated for the treatment of patients with multiple myeloma.

At a Glance

Licensee Indication Royalty
Amgen Multiple Myeloma 1.5-3.0%

EVOMELA

Captisol-enabled formulation of Melphalan which is used for stem cell transplant conditioning in multiple myeloma that was approved by FDA in March 2016. Captisol improves product stability and enables the removal of propylene glycol, which is associated with renal and cardiac toxicities.

At a Glance

Partner Indication Royalty
Spectrum Oncology 20%

Additional Marketed Products

IV Voriconazole

Captisol-enabled IV formulation of voriconazole

At a Glance

Partner Indication Royalty
Alvogen Infectious Disease Material sales only

Duavee

DUAVEE (conjugated estrogens/bazedoxifene) is a progesterone-free treatment for moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause and aids in the prevention of postmenopausal osteoporosis.

At a Glance

Partner Indication Royalty
Pfizer Menopause 0.5-2.5%

Viviant/Conbriza

Viviant/Conbriza™ (bazedoxifene) is a synthetic drug that was specifically designed to reduce the risk of osteoporotic fractures, while at the same time protecting breast and uterine tissue.

At a Glance

Partner Indication Royalty
Pfizer Osteoporosis 0.5-2.5%

Nexterone

NEXTERONE (amiodarone HCl) Premixed Injection is indicated for initiation of treatment and prophylaxis for frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to the therapy.

At a Glance

Partner Indication Royalty
Baxter Arrhythmia Undisclosed

Noxafil-IV

Captisol-enabled IV formulation of Noxafil

At a Glance

Partner Indication Royalty
Merck Infectious Disease Material sales only

Carnexiv

Captisol-enabled injectable formulation of carbamazepine indicated as replacement therapy for oral carbamazepine when oral administration is temporarily not feasible.

At a Glance

Partner Indication Royalty
Lundbeck CNS 2.75%